|№||Акция||Дивидендная дох-сть за 4 квартала|
|1||Briggs & Stratton, акция обыкновенная||48.68%|
|2||Orient Overseas International, акция обыкновенная||42.23%|
|3||International Airlines Group, акция обыкновенная||27.34%|
|4||Vermilion Energy Inc, акция обыкновенная||24.14%|
|5||RBS, акция обыкновенная||18.19%|
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan. The company’s drugs are marketed in approximately 90 countries worldwide. The company has an international marketing network, including Japan and 13 overseas bases in the U.S., Europe, and Asia. From these bases, the company markets its original products.The company operates its business in two categories, Pharmaceutical business and Other businesses.
The Pharmaceutical business represents the ethical drug business and healthcare business. Other businesses include business activities involving the production and marketing of a range of products, including clinical diagnostics, photographic chemicals, and inorganic chemicals. In November 2009, Amylin Pharmaceuticals Inc. and Takeda Pharmaceutical Co. Ltd. announced that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications.Takeda Pharmaceutical Company Limited was founded in 1781.Показать все Скрыть